Angiotensin I—converting enzyme and angiotensinogen gene polymorphisms in non—insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a caucasian mediterranean population

Metabolism ◽  
1997 ◽  
Vol 46 (8) ◽  
pp. 976-980 ◽  
Author(s):  
C. Gutiérrez ◽  
J. Vendrell ◽  
R. Pastor ◽  
C. Llor ◽  
C. Aguilar ◽  
...  
1996 ◽  
Vol 50 (2) ◽  
pp. 657-664 ◽  
Author(s):  
Hiroaki Yoshida ◽  
Satoru Kuriyama ◽  
Yoshihito Atsumi ◽  
Haruo Tomonari ◽  
Tetsuya Mitarai ◽  
...  

1998 ◽  
Vol 9 (9) ◽  
pp. 1664-1669
Author(s):  
W Grzeszczak ◽  
M J Zychma ◽  
B Lacka ◽  
E Zukowska-Szczechowska

Nephropathy is a frequent complication of long-term diabetes. Strong evidence exists that genetic predisposition plays a major role in the development of diabetic nephropathy. The role of the angiotensin I-converting enzyme gene (ACE) in the susceptibility to nephropathy in diabetes, especially in non-insulin dependent diabetes mellitus (NIDDM), remains unclear. This study examines the association of two ACE polymorphisms: a 287-bp insertion/deletion (I/D) in intron 16 and PstI (A/G substitution in intron 7; alleles P/M) with renal complications in 941 NIDDM patients. From this group, for further analysis 127 patients were selected with overt proteinuria or chronic renal failure, 335 patients with microalbuminuria, and a control group of 254 normoalbuminuric patients with a diabetes duration of at least 10 yr. No significant differences in the distribution of ACE I/D and PstI genotypes or allele frequencies were observed between the examined groups. The results of this study strongly suggest that there is no association between the ACE gene I/D and PstI polymorphisms and nephropathy in NIDDM.


Sign in / Sign up

Export Citation Format

Share Document